SK Chemical took approval of an anti-coagulation drug.

Published: 2004-06-09 06:58:00

Updated: 2004-06-09 06:58:00

SK Chemical and SK Pharmaceutical secured the KFDA approval of "Hootan", an anti-coagulation drug, for the treatment of blood coagulation and thrombo-embolism for patients on blood dialysis and acute pancreatitis, on June 1. Hootan will be sold in Korea under the technical licence agreement with Japanese Dorii Pharm. Co.

Hootan is a very safe anti-coagulating drug without any side reactions...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.